Literature DB >> 25019920

Evaluations and comparisons of treatment effects based on best combinations of biomarkers with applications to biomedical studies.

Albert Vexler1, Xiwei Chen, Jihnhee Yu.   

Abstract

Many clinical and biomedical studies evaluate treatment effects based on multiple biomarkers that commonly consist of pre- and post-treatment measurements. Some biomarkers can show significant positive treatment effects, while other biomarkers can reflect no effects or even negative effects of the treatments, giving rise to a necessity to develop methodologies that may correctly and efficiently evaluate the treatment effects based on multiple biomarkers as a whole. In the setting of pre- and post-treatment measurements of multiple biomarkers, we propose to apply a receiver operating characteristic (ROC) curve methodology based on the best combination of biomarkers maximizing the area under the receiver operating characteristic curve (AUC)-type criterion among all possible linear combinations. In the particular case with independent pre- and post-treatment measurements, we show that the proposed method represents the well-known Su and Liu's (1993) result. Further, proceeding from derived best combinations of biomarkers' measurements, we propose an efficient technique via likelihood ratio tests to compare treatment effects. We show an extensive Monte Carlo study that confirms the superiority of the proposed test in comparison with treatment effects based on multiple biomarkers in a paired data setting. For practical applications, the proposed method is illustrated with a randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients as well as a treatment study for children with attention deficit-hyperactivity disorder and severe mood dysregulation.

Entities:  

Keywords:  area under the curve; best linear combination; likelihood ratio test; paired data; receiver operating characteristic; treatment effect

Mesh:

Substances:

Year:  2014        PMID: 25019920      PMCID: PMC4148056          DOI: 10.1089/cmb.2014.0097

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  11 in total

1.  Generalized treatment effects for clinical trials.

Authors:  W W Hauck; T Hyslop; S Anderson
Journal:  Stat Med       Date:  2000-04-15       Impact factor: 2.373

2.  Combining diagnostic test results to increase accuracy.

Authors:  M S Pepe; M L Thompson
Journal:  Biostatistics       Date:  2000-06       Impact factor: 5.899

3.  Testing equality of generalized treatment effects.

Authors:  Lili Tian; Xinmin Li; Li Yan
Journal:  J Biopharm Stat       Date:  2012       Impact factor: 1.051

4.  Estimation of ROC curves based on stably distributed biomarkers subject to measurement error and pooling mixtures.

Authors:  Albert Vexler; Enrique F Schisterman; Aiyi Liu
Journal:  Stat Med       Date:  2008-01-30       Impact factor: 2.373

5.  Confidence intervals for P(Y1>Y2) with normal outcomes in linear models.

Authors:  Lili Tian
Journal:  Stat Med       Date:  2008-09-20       Impact factor: 2.373

6.  Comparing the areas under more than two independent ROC curves.

Authors:  D K McClish
Journal:  Med Decis Making       Date:  1987 Jul-Sep       Impact factor: 2.583

7.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

8.  Two-sample density-based empirical likelihood ratio tests based on paired data, with application to a treatment study of attention-deficit/hyperactivity disorder and severe mood dysregulation.

Authors:  Albert Vexler; Wan-Min Tsai; Gregory Gurevich; Jihnhee Yu
Journal:  Stat Med       Date:  2012-06-20       Impact factor: 2.373

9.  A min-max combination of biomarkers to improve diagnostic accuracy.

Authors:  Chunling Liu; Aiyi Liu; Susan Halabi
Journal:  Stat Med       Date:  2011-04-07       Impact factor: 2.373

10.  Maximum likelihood ratio tests for comparing the discriminatory ability of biomarkers subject to limit of detection.

Authors:  Albert Vexler; Aiyi Liu; Ekaterina Eliseeva; Enrique F Schisterman
Journal:  Biometrics       Date:  2007-11-19       Impact factor: 1.701

View more
  1 in total

1.  Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors.

Authors:  Jeffrey L Woodhead; William J Brock; Sharin E Roth; Susan E Shoaf; Kim L R Brouwer; Rachel Church; Tom N Grammatopoulos; Linsey Stiles; Scott Q Siler; Brett A Howell; Merrie Mosedale; Paul B Watkins; Lisl K M Shoda
Journal:  Toxicol Sci       Date:  2016-09-21       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.